It was suggested that the stimulation of HBECs with IL-13 affected the expression of many SARS-CoV-2-related genes and largely inhibited the infection of these cells against SARS-CoV-2, which just explained the relatively low prevalence of asthma in patients diagnosed with COVID-19. This evidence concerns the gene IL13 and asthma.